These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22867439)

  • 1. What inference for two-stage phase II trials?
    Porcher R; Desseaux K
    BMC Med Res Methodol; 2012 Aug; 12():117. PubMed ID: 22867439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.
    Zhao J; Yu M; Feng XP
    BMC Med Res Methodol; 2015 Jun; 15():48. PubMed ID: 26048655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation and expected sample size in Simon's two-stage designs that stop as early as possible.
    Daletzakis A; van den Bor R; Jonker MA; Roes KCB; van Tinteren H
    Pharm Stat; 2022 Sep; 21(5):879-894. PubMed ID: 35191174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimax and admissible adaptive two-stage designs in phase II clinical trials.
    Shan G; Zhang H; Jiang T
    BMC Med Res Methodol; 2016 Aug; 16():90. PubMed ID: 27485595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis testing for two-stage designs with over or under enrollment.
    Zeng D; Gao F; Hu K; Jia C; Ibrahim JG
    Stat Med; 2015 Jul; 34(16):2417-26. PubMed ID: 25809924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interval and point estimation in adaptive Phase II trials with binary endpoint.
    Nhacolo A; Brannath W
    Stat Methods Med Res; 2019 Sep; 28(9):2635-2648. PubMed ID: 29921157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proper inference from Simon's two-stage designs.
    Koyama T; Chen H
    Stat Med; 2008 Jul; 27(16):3145-54. PubMed ID: 17960777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.
    Shimura M; Maruo K; Gosho M
    Pharm Stat; 2018 Sep; 17(5):400-413. PubMed ID: 29687592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the estimation of the binomial probability in multistage clinical trials.
    Jung SH; Kim KM
    Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.
    Jung SH
    Contemp Clin Trials; 2015 May; 42():9-17. PubMed ID: 25749311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point estimation in adaptive enrichment designs.
    Kunzmann K; Benner L; Kieser M
    Stat Med; 2017 Nov; 36(25):3935-3947. PubMed ID: 28783881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the binomial probabilities in a two-stage phase II clinical trial with two co-primary endpoints.
    Sun Y; Zhang X; Tan X; Tu D
    Contemp Clin Trials; 2021 Jun; 105():106390. PubMed ID: 33819639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal two-stage designs allowing flexibility in number of subjects for phase II clinical trials.
    Masaki N; Koyama T; Yoshimura I; Hamada C
    J Biopharm Stat; 2009 Jul; 19(4):721-31. PubMed ID: 20183436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of secondary endpoints in two-stage phase II oncology trials.
    Kunz CU; Kieser M
    Stat Med; 2012 Dec; 31(30):4352-68. PubMed ID: 22930470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting for treatment selection in phase II/III clinical trials with time to event data.
    Khan JN; Kimani PK; Glimm E; Stallard N
    Stat Med; 2023 Jan; 42(2):146-163. PubMed ID: 36419206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size re-estimation in paired comparative diagnostic accuracy studies with a binary response.
    McCray GPJ; Titman AC; Ghaneh P; Lancaster GA
    BMC Med Res Methodol; 2017 Jul; 17(1):102. PubMed ID: 28705147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point estimation and p-values in phase II adaptive two-stage designs with a binary endpoint.
    Kunzmann K; Kieser M
    Stat Med; 2017 Mar; 36(6):971-984. PubMed ID: 28028823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.